ESSEX BIO-TECH (01061) and OSTEOPORE have entered into an exclusive distribution agreement.
Billion Win Biotech (01061) announced that on January 15, 2026, its wholly owned subsidiary Majeton Pte Ltd (Majeton) entered into an exclusive distribution agreement with Osteopore International Pte Ltd (Osteopore). Osteopore is a global leader in 3D printing of biomimetic and biodegradable implants.
Essex Bio-Tech (01061) announced on January 15, 2026, that its wholly-owned subsidiary Majeton Pte Ltd (Majeton) has entered into an exclusive distribution agreement with Osteopore International Pte Ltd (Osteopore). Osteopore is a global leader in 3D printed bioresorbable implants.
Under the distribution agreement, Osteopore has appointed Majeton as its exclusive distributor in mainland China, Hong Kong, and Macau, distributing innovative dental, orthodontic, and maxillofacial products. The expected contract value of the distribution agreement exceeds 12 million RMB, including advance payments and milestone payments, with the opportunity for additional payments through product procurement and supply.
The collaboration with Osteopore marks a milestone for the group in the oral care market and expands the group's product line of dental, orthodontic, and maxillofacial solutions, collectively helping the group pursue sustainable growth in the Chinese market.
Related Articles
JU TENG INTL (03336) suspected of being hit by a cyber attack has launched a comprehensive investigation.
Air China Limited (00753) December passenger turnover increased by 10% year-on-year.
HORIZONROBOT-W (09660) has awarded 12.7967 million shares of Class B common stock as incentives following its initial public offering.
JU TENG INTL (03336) suspected of being hit by a cyber attack has launched a comprehensive investigation.
Air China Limited (00753) December passenger turnover increased by 10% year-on-year.
HORIZONROBOT-W (09660) has awarded 12.7967 million shares of Class B common stock as incentives following its initial public offering.
